Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Jared Weiss walks sufferers by way of the therapeutic potential viability of intratumoral therapies amongst these with lung most cancers.JNJ-1900 (NBTXR3) is...
Utilizing a 14-gene check to information chemotherapy considerably improved disease-free survival in sufferers with early nonsquamous lung most cancers.Amongst sufferers with stage 1a...
How synthetic intelligence is getting used to enhance the work of consultants treating sufferers with prostate most cancers.For sufferers with prostate most cancers,...
The twin-targeting CAR T-cell remedy KITE-363 confirmed constructive response charges and manageable unwanted effects in relapsed or refractory B-cell lymphoma.Amongst sufferers with relapsed/refractory...
Including subcutaneous sasanlimab to Bacillus Calmette-Guérin (BCG) improved recurrence-free survival in non–muscle-invasive bladder most cancers, in accordance with findings from the CREST trial...
